Package 82954-0100-1

Brand: rivive

Generic: naloxone hydrochloride
NDC Package

Package Facts

Identity

Package NDC 82954-0100-1
Digits Only 8295401001
Product NDC 82954-0100
Product ID 82954-0100_4e308ade-33a2-4daa-acdd-af1559b90c17
Description

2 VIAL, SINGLE-DOSE in 1 CARTON (82954-0100-1) / .1 mL in 1 VIAL, SINGLE-DOSE

Marketing

Marketing Status
Marketed Since 2024-01-02
Brand rivive
Generic naloxone hydrochloride
Sample Package No

Linked Drug Pages (1)

RiVive ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["NASAL"], "spl_id": "4e308ade-33a2-4daa-acdd-af1559b90c17", "openfda": {"unii": ["F850569PQR"], "rxcui": ["2673091"], "spl_set_id": ["1c4f1b9d-1c70-4666-a90e-2f5d2c670d4d"], "manufacturer_name": ["Harm Reduction Therapeutics, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "2 VIAL, SINGLE-DOSE in 1 CARTON (82954-0100-1)  / .1 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "82954-0100-1", "marketing_start_date": "20240102"}], "brand_name": "RiVive", "product_id": "82954-0100_4e308ade-33a2-4daa-acdd-af1559b90c17", "dosage_form": "SPRAY", "pharm_class": ["Opioid Antagonist [EPC]", "Opioid Antagonists [MoA]"], "product_ndc": "82954-0100", "generic_name": "naloxone hydrochloride", "labeler_name": "Harm Reduction Therapeutics, Inc.", "product_type": "HUMAN OTC DRUG", "brand_name_base": "RiVive", "active_ingredients": [{"name": "NALOXONE HYDROCHLORIDE", "strength": "3 mg/.1mL"}], "application_number": "NDA217722", "marketing_category": "NDA", "marketing_start_date": "20240102", "listing_expiration_date": "20271231"}